TORNTPHARM NSE filing

Torrent Pharma Announces NCLT Convened Meeting of Equity Shareholders on April 28, 2026

The RealCase readLow impact Neutral

Torrent Pharmaceuticals Limited will hold an NCLT convened meeting for equity shareholders on April 28, 2026. The meeting will be conducted via video conference. This announcement follows an NCLT order dated March 23, 2026.

Why it matters

This is a routine disclosure related to a regulatory directive and does not involve significant business changes or financial outcomes.

The market read

The announcement is a procedural disclosure regarding a shareholder meeting as directed by the NCLT, with no immediate financial implications.

Torrent Pharmaceuticals Limited has announced the details of a National Company Law Tribunal (NCLT) convened meeting of its equity shareholders. This meeting has been scheduled as per the NCLT's order dated 23rd March, 2026.

The meeting is set to take place on Tuesday, 28th April, 2026, commencing at 10:00 a.m. (IST). Shareholders will participate through Video Conferencing or Other Audio-Visual Means.

Copies of the newspaper cuttings published on 28th March, 2026, in Indian Express (English) and Sandesh (Gujarati) regarding this meeting have been provided to the stock exchanges.

Filing to action

What to do with a filing like this

Torrent Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under shareholder meetings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Torrent Pharmaceuticals Limited. Read the original for the full detail.

View original filing